143 related articles for article (PubMed ID: 385514)
1. C. parvum treatment of transplanted rat tumours of spontaneous origin.
Willmott N; Pimm MV; Baldwin RW
Int J Cancer; 1979 Sep; 24(3):323-8. PubMed ID: 385514
[TBL] [Abstract][Full Text] [Related]
2. BCG treatment of transplanted rat tumours of spontaneous origin.
Pimm MV; Cook AJ; Hopper DG; Dickinson AM; Baldwin RW
Int J Cancer; 1978 Oct; 22(4):426-32. PubMed ID: 700898
[TBL] [Abstract][Full Text] [Related]
3. Combined radiotherapy and Corynebacterium parvum treatment of rat tumors with different immunogenicity.
Moroson H; Stowe S; Rotman M; Schechter M
Int J Radiat Oncol Biol Phys; 1978; 4(7-8):649-55. PubMed ID: 711536
[No Abstract] [Full Text] [Related]
4. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
Moore K; McBride WH
Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
[TBL] [Abstract][Full Text] [Related]
5. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
Woodruff MF; Dunbar N
Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
[TBL] [Abstract][Full Text] [Related]
6. C. parvum immuntherapy of transplanted rat tumours.
Pimm MV; Baldwin RW
Int J Cancer; 1977 Dec; 20(6):923-32. PubMed ID: 591131
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy and Corynebacterium parvum in the treatment of murine tumors.
Suit HD; Sedlacek RS; Silobrcic V; Linggood RM
Cancer; 1976 Jun; 37(6):2573-9. PubMed ID: 949676
[TBL] [Abstract][Full Text] [Related]
8. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
Likhite VV
J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
[TBL] [Abstract][Full Text] [Related]
9. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
Bomford R
Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cancer using Corynebacterium parvum: similarity of two preparations in four animal tumor models.
Bartlett GL; Kreider JW; Purnell DM
Cancer; 1980 Aug; 46(4):685-91. PubMed ID: 7397633
[TBL] [Abstract][Full Text] [Related]
11. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
Woodruff MF; McBride WH; Dunbar N
Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
[TBL] [Abstract][Full Text] [Related]
12. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
Woodruff MF; Whitehead VL; Speedy G
Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
[TBL] [Abstract][Full Text] [Related]
13. Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.
Woodruff MF; Inchley MP; Dunbar N
Br J Cancer; 1972 Apr; 26(2):67-76. PubMed ID: 5038327
[TBL] [Abstract][Full Text] [Related]
14. Effect of C. parvum and active specific immunotherapy on intracerebral transplants of a murine fibrosarcoma.
Woodruff MF; Hitchcock E; Whitehead VL
Br J Cancer; 1977 May; 35(5):687-92. PubMed ID: 861152
[No Abstract] [Full Text] [Related]
15. Methanol extraction residue of BCG in the treatment of transplanted rat tumours.
Hopper DG; Pimm MV; Baldwin RW
Br J Cancer; 1975 Feb; 31(2):176-81. PubMed ID: 169861
[TBL] [Abstract][Full Text] [Related]
16. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
Thomson AW; Cruickshank N; Fowler EF
Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
[No Abstract] [Full Text] [Related]
17. Host responses in adjuvant contact suppression of experimental rat tumours.
Pimm MV; Hopper DG; Baldwin RW
Dev Biol Stand; 1977 Apr 13-15; 38():349-54. PubMed ID: 344098
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
Keller R
J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
[TBL] [Abstract][Full Text] [Related]
20. Study of the mechanism of Corynebacterium parvum anti-tumour activity. I. Protective effect on the growth of two syngeneic tumours.
Mazurek C; Chalvet H; Stiffel CL; Biozzi G
Int J Cancer; 1976 Apr; 17(4):511-7. PubMed ID: 946965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
